Paper51442
Letter: Clozapine and agranulocytosis.
Idänpään-Heikkilä J and 3 others. Lancet, 1975. Cited by 138 papers, by iCite.
Cite this record
ConductScience Library. Letter: Clozapine and agranulocytosis. Papers, record 51442. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/51442
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Agranulocytosis | Major topic |
| Clozapine | Major topic |
| Dibenzazepines | Major topic |
| Adult | |
| Female | |
| Humans | |
| Male | |
| Middle Aged |
Source PubMed
Cited by47
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 138 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42713824 | A Systematic Review and a VigiBase Study of Accidental Clozapine Intoxications in Children and Adolescents. | Hum Psychopharmacol | 2026 | https://conductscience.org/library/papers/42713824 | PubMed |
| 42538420 | A critical review of the early clozapine trials published in German and a discussion of the many unresolved issues left by these trials. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/42538420 | PubMed |
| 41718215 | Trends in Antipsychotic Drug Use in the United States, 2000-2016. | Pharmacy (Basel) | 2026 | https://conductscience.org/library/papers/41718215 | PubMed |
| 41651559 | Risk of neutropenia-related hospitalisation among clozapine initiators. | BMJ Ment Health | 2026 | https://conductscience.org/library/papers/41651559 | PubMed |
| 40198784 | Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part II: A Review of Fatal Outcomes in US Pharmacovigilance Data and Proposed Changes. | J Clin Psychopharmacol | 2025 | https://conductscience.org/library/papers/40198784 | PubMed |
| 40198781 | Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part I: A Review of the Pharmacokinetic Literature and Proposed Changes. | J Clin Psychopharmacol | 2025 | https://conductscience.org/library/papers/40198781 | PubMed |
| 39946132 | Physician Experiences With and Perspectives on Clozapine Prescribing. | JAMA Netw Open | 2025 | https://conductscience.org/library/papers/39946132 | PubMed |
| 39937830 | Characterization of the atypical antipsychotic drug aripiprazole cytotoxicity in the neutrophil model cell line HL-60. | PLoS One | 2025 | https://conductscience.org/library/papers/39937830 | PubMed |
| 39621136 | Evaluating the adverse drug reactions to clozapine in populations of children and adolescents: insights from VigiBase data. | Eur Child Adolesc Psychiatry | 2025 | https://conductscience.org/library/papers/39621136 | PubMed |
| 39054072 | Roles of Individual Human Cytochrome P450 Enzymes in Drug Metabolism. | Pharmacol Rev | 2024 | https://conductscience.org/library/papers/39054072 | PubMed |
| 38766824 | Is Antipsychotic Drug Use During Pregnancy Associated with Increased Malformation Rates and Worsening of Maternal and Infant Outcomes? A Systematic Review. | Curr Neuropharmacol | 2024 | https://conductscience.org/library/papers/38766824 | PubMed |
| 37624540 | Toxicity and Adverse Effects in Clozapine-Related Presentations to a Medical Toxicology Service in Western Sydney. | J Med Toxicol | 2023 | https://conductscience.org/library/papers/37624540 | PubMed |
| 36994117 | Second to none: rationale, timing, and clinical management of clozapine use in schizophrenia. | Ther Adv Psychopharmacol | 2023 | https://conductscience.org/library/papers/36994117 | PubMed |
| 36850057 | Reflections on the Lack of Consideration of Ethnic Ancestry to Stratify Clozapine Dosing. | Psychiatry Investig | 2023 | https://conductscience.org/library/papers/36850057 | PubMed |
| 36000301 | Long-lasting leukocytosis in patients with schizophrenia treated with clozapine after electroconvulsive therapy : ECT stabilizes white blood cell count. | Sci Prog | 2022 | https://conductscience.org/library/papers/36000301 | PubMed |
| 35288577 | Distinctive pattern of neutrophil count change in clozapine-associated, life-threatening agranulocytosis. | Schizophrenia (Heidelb) | 2022 | https://conductscience.org/library/papers/35288577 | PubMed |
| 35046764 | Impact of a Novel Strategy for Critical Values Communication for the Management of Patients Treated with Clozapine. | EJIFCC | 2021 | https://conductscience.org/library/papers/35046764 | PubMed |
| 34104415 | Prescription attitudes and practices regarding clozapine among Serbian psychiatrists: results of a nationwide survey. | Ther Adv Psychopharmacol | 2021 | https://conductscience.org/library/papers/34104415 | PubMed |
| 34083506 | Genetic risk of clozapine-induced leukopenia and neutropenia: a genome-wide association study. | Transl Psychiatry | 2021 | https://conductscience.org/library/papers/34083506 | PubMed |
| 33846298 | HLA-DQB1 6672G>C (rs113332494) is associated with clozapine-induced neutropenia and agranulocytosis in individuals of European ancestry. | Transl Psychiatry | 2021 | https://conductscience.org/library/papers/33846298 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/51442
GET https://conductscience.org/api/papers/v1/51442/cited_by?page=2